Year |
Citation |
Score |
2020 |
Lakhani NJ, Patnaik A, Liao JB, Moroney JW, Miller DS, Fleming GF, Axt M, Wang YV, Agoram B, Volkmer J, Maute R, Schroeder A, Chico I, Chao M, Takimoto CH, et al. A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients. Journal of Clinical Oncology. 38: 18-18. DOI: 10.1200/Jco.2020.38.5_Suppl.18 |
0.541 |
|
2020 |
Fisher GA, Lakhani NJ, Eng C, Hecht JR, Bendell JC, Philip PA, O'Dwyer PJ, Johnson B, Kardosh A, Ippolito TM, Wang YV, Agoram B, Volkmer J, Maute R, Chico I, et al. A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients. Journal of Clinical Oncology. 38: 114-114. DOI: 10.1200/Jco.2020.38.4_Suppl.114 |
0.323 |
|
2020 |
Agoram B, Jin C, Maute R, Takimoto CH, Chao M, Sallman DA. Pharmacokinetic (PK)-pharamcodynamic (PD) analysis and receptor occupancy data to support every other week maintenance dosing of magrolimab in combination with azacitidine in MDS/AML patients. Journal of Clinical Oncology. 38: e15098-e15098. DOI: 10.1200/Jco.2020.38.15_Suppl.E15098 |
0.342 |
|
2020 |
Sallman DA, Al Malki M, Asch AS, Lee DJ, Kambhampati S, Donnellan WB, Bradley TJ, Vyas P, Jeyakumar D, Marcucci G, Komrokji RS, Van Elk J, Lin M, Maute R, Volkmer J, et al. Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in MDS and AML patients: Phase Ib results. Journal of Clinical Oncology. 38: 7507-7507. DOI: 10.1200/Jco.2020.38.15_Suppl.7507 |
0.363 |
|
2019 |
Maute RL, Chen JY, Marjon KD, Duan J, Choi T, Chao M, Takimoto CH, Agoram B, Volkmer J. Translational Study of Cell Surface Proteins in Non-Hodgkin Lymphoma Patients Treated with the First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Rituximab Blood. 134: 5229-5229. DOI: 10.1182/Blood-2019-127526 |
0.771 |
|
2018 |
Barkal AA, Weiskopf K, Kao KS, Gordon SR, Rosental B, Yiu YY, George BM, Markovic M, Ring NG, Tsai JM, McKenna KM, Ho PY, Cheng RZ, Chen JY, Barkal LJ, ... ... Maute RL, et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nature Immunology. 19: 76-84. PMID 29180808 DOI: 10.1038/S41590-017-0004-Z |
0.614 |
|
2017 |
Barkal, AA, Weiskopf K, Kao KS, Gordon SR, Rosental B, Yiu YY, George BM, Markovic M, Ring NG, Tsai JM, McKenna KM, Ho PY, Cheng RZ, Chen JY, ... ... Maute RL, et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy Nature Immunology. PMID 29180808 DOI: 10.1038/s41590-017-0004-z |
0.464 |
|
2017 |
Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, Gupta R, Tsai JM, Sinha R, Corey D, Ring AM, Connolly AJ, Weissman IL. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. PMID 28514441 DOI: 10.1038/Nature22396 |
0.733 |
|
2016 |
Mayer AT, Natarajan A, Gordon S, Maute R, McCracken M, Ring A, Weissman I, Gambhir SS. Practical ImmunoPET radiotracer design considerations for human immune checkpoint imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27980047 DOI: 10.2967/Jnumed.116.177659 |
0.774 |
|
2016 |
Pascolutti R, Sun X, Kao J, Maute RL, Ring AM, Bowman GR, Kruse AC. Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant. Structure (London, England : 1993). PMID 27618663 DOI: 10.1016/J.Str.2016.06.026 |
0.743 |
|
2016 |
Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D, Jude K, et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. The Journal of Clinical Investigation. PMID 27294525 DOI: 10.1172/Jci81603 |
0.744 |
|
2016 |
Gordon SR, Maute R, Mayer A, McCracken M, Natarajan A, Guo N, Kimura R, Tsai JM, Manglik A, Kruse A, Gambhir S, Weissman IL, Ring AM. Abstract B101: Engineered PD-1 variants as immunotherapies for cancer Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B101 |
0.803 |
|
2015 |
Maute RL, Gordon SR, Mayer AT, McCracken MN, Natarajan A, Ring NG, Kimura R, Tsai JM, Manglik A, Kruse AC, Gambhir SS, Weissman IL, Ring AM. Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging. Proceedings of the National Academy of Sciences of the United States of America. 112: E6506-14. PMID 26604307 DOI: 10.1073/Pnas.1519623112 |
0.758 |
|
2015 |
Maute RL, Gordon SR, Mayer AT, McCracken MN, Natarajan A, Ring NG, Kimura R, Tsai JM, Manglik A, Kruse AC, Gambhir SS, Weissman IL, Ring AM. Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging Proceedings of the National Academy of Sciences. PMID 26604307 |
0.536 |
|
2014 |
Schneider C, Setty M, Holmes AB, Maute RL, Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R, Basso K. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 111: 8185-90. PMID 24843176 DOI: 10.1073/Pnas.1322466111 |
0.436 |
|
2014 |
Maute RL, Dalla-Favera R, Basso K. RNAs with multiple personalities. Wiley Interdisciplinary Reviews. Rna. 5: 1-13. PMID 24039180 DOI: 10.1002/Wrna.1193 |
0.387 |
|
2014 |
Weiskopf K, Ring AM, Guo N, Schnorr PJ, Maute RL, Volkmer J, Weissman IL. Direct SIRPa Blockade Augments Macrophage Responses to Therapeutic Anticancer Antibodies Blood. 124: 2729-2729. DOI: 10.1182/Blood.V124.21.2729.2729 |
0.786 |
|
2013 |
Maute RL, Schneider C, Sumazin P, Holmes A, Califano A, Basso K, Dalla-Favera R. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 110: 1404-9. PMID 23297232 DOI: 10.1073/Pnas.1206761110 |
0.462 |
|
2010 |
Schneider C, Maute RL, Sumazin P, Brahmachary M, Setty M, Pasqualucci L, Rosolen A, Leslie C, Basso K, Dalla-Favera R. MiR-28 Silencing In Germinal Center-Derived Lymphomas Blood. 116: 703-703. DOI: 10.1182/Blood.V116.21.703.703 |
0.431 |
|
2009 |
Basso K, Sumazin P, Morozov P, Schneider C, Maute RL, Kitagawa Y, Mandelbaum J, Haddad J, Chen CZ, Califano A, Dalla-Favera R. Identification of the human mature B cell miRNome. Immunity. 30: 744-52. PMID 19446474 DOI: 10.1016/J.Immuni.2009.03.017 |
0.428 |
|
2007 |
Basso K, Morozov P, Kitagawa Y, Maute RL, Rosolen A, Chen C, Califano A, Dalla-Favera R. Investigating Mature B-Cell Lymphomas by MicroRNA Profiling. Blood. 110: 3185-3185. DOI: 10.1182/Blood.V110.11.3185.3185 |
0.411 |
|
Low-probability matches (unlikely to be authored by this person) |
1966 |
Benson RH, Maute RL. The measurement of beta radioactivity in gas samples using a plastic scintillator cell The International Journal of Applied Radiation and Isotopes. 17: 488-489. |
0.059 |
|
2013 |
Ross AP, Mansilla MA, Choe Y, Helminski S, Sturm R, Maute RL, May SR, Hozyasz KK, Wójcicki P, Mostowska A, Davidson B, Adamopoulos IE, Pleasure SJ, Murray JC, Zarbalis KS. A mutation in mouse Pak1ip1 causes orofacial clefting while human PAK1IP1 maps to 6p24 translocation breaking points associated with orofacial clefting. Plos One. 8: e69333. PMID 23935987 DOI: 10.1371/journal.pone.0069333 |
0.056 |
|
1977 |
Cho BY, Utt OL, Maute RE. OPTICAL CAVITY METHOD OF INFRARED MOISTURE MEASUREMENT . |
0.036 |
|
1962 |
Benson RH, Maute RL. Liquid scintillation counting of tritium: Improvements in sensitivity by efficient light collection Analytical Chemistry. 34: 1122-1124. |
0.026 |
|
1955 |
Maute RL, Owens ML, Slate JL. Rapid determination of traces of iron and copper in acrylonitrile Analytical Chemistry. 27: 1614-1616. |
0.022 |
|
1985 |
Maute RE, Gournay IS. DETERMINATION OF RESIDUAL OIL SATURATION WITH THE BOREHOLE GRAVITY METER Society of Petroleum Engineers of Aime, (Paper) Spe. 185-190. |
0.021 |
|
1974 |
Maute RE, D'Amato DP, Blatt SL. Extended table of angular-distribution coefficients for (gamma, particle) and (particle, gamma) reactions Atomic Data and Nuclear Data Tables. 13: 499-624. DOI: 10.1016/0092-640X(74)90004-7 |
0.019 |
|
1989 |
Maute RE, Lyle WD, Sprunt ES. Improved data analysis method of determining archie parameters 'm' and 'n' from core data Society of Petroleum Engineers of Aime, (Paper) Spe. |
0.018 |
|
1954 |
Maute RL, Owens ML. Determination of low hydrogen cyanide in acrylonitrile Analytical Chemistry. 26: 1723-1725. |
0.017 |
|
1962 |
Maute RL, Benson RH, Stroud JD, Hodgson N, Beasecker DR. Evaluation of methods for the determination of mercuric chloride on carbon Analytical Chemistry. 34: 553-555. |
0.013 |
|
1992 |
Maute RE, Lyle WD, Sprunt ES. Improved data-analysis method determines archie parameters from core data Jpt, Journal of Petroleum Technology. 44: 103-107. |
0.01 |
|
2009 |
Zarbalis K, Choe Y, Maute RL, Peterson AS, Pleasure SJ. Manta ray a novel ENU mutant with brain and craniofacial defects Developmental Biology. 331: 494-495. DOI: 10.1016/j.ydbio.2009.05.407 |
0.01 |
|
1999 |
Maute R. Aktiv absorbierende Schalldämpfer für Geräte und Anlagen Vdi Berichte. 453-459. |
0.01 |
|
1992 |
Maute RE, Lyle WD, Sprunt ES. 'Improved data analysis method of determining Archie parameters 'm' and 'n' from core data' Society of Petroleum Engineers of Aime, (Paper) Spe. 1-10. |
0.01 |
|
1968 |
Maute RL, Benson RH, Martelli E. Spectrophotometric determination of methanol in lactic acid through the hydrolysis and vacuum stripping of methyl lactate Analytical Chemistry. 40: 1380-1381. |
0.01 |
|
1966 |
Benson RH, Maute RL. Apparatus for the precise metering of radioactive gases or solutions The International Journal of Applied Radiation and Isotopes. 17: 427-430. |
0.01 |
|
1962 |
Smith GD, Maute RL. Determination of catalyst residues in polyolefins by x-ray emission spectrometry Analytical Chemistry. 34: 1733-1735. |
0.01 |
|
1956 |
Maute RL, Owens ML. Rapid determination of carbonyl content in acrylonitrile Analytical Chemistry. 28: 1312-1314. |
0.01 |
|
1955 |
Owens ML, Maute RL. Nonaqueous titration of dilute acids and bases in acrylonitrile Analytical Chemistry. 27: 1177-1178. |
0.01 |
|
Hide low-probability matches. |